North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal Antibodies, Antineoplastic, Hedgehog Pathway Inhibitors, and Others), By Route of Administration (Oral, Topical, and Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Forecast, 2021-2028

Region : North America | Format: PDF | Report ID: FBI106348

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. New Product Launches, Key Players
2. Key Industry Developments Partnerships, Mergers, and Acquisitions
3. Overview of Regulatory Scenario for the Approval of Drugs in the U.S.
4. Impact of COVID 19 on the Market
North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Analysis, Insights and Forecast, 2017-2028
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Monoclonal Antibodies
  2. Antineoplastic
  3. Hedgehog Pathway Inhibitors
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2020)
3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
  1. F. Hoffmann-La Roche Ltd.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Merck & Co., Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Sanofi
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. Eli Lilly and Company
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Regeneron Pharmaceuticals Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. Bausch Health Companies Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Sun Pharmaceutical Industries Ltd.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  8. Amgen Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  9. LEO Pharma A/S
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations

List of Figures

Table 01: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) Forecast, by Country, 2017-2028

Table 02: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) Forecast, By Drug Class, 2017-2028

Table 03: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) forecast, by Route of Administration, 2017-2028

Table 04: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) forecast, by Distribution Channel, 2017-2028

List of Tables

Figure 01: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Value (USD million), by Country, 2020 & 2028

Figure 02: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Country, 2020

Figure 03: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Drug Class, 2020

Figure 04: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Route of Administration, 2020

Figure 05: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Distribution Channel, 2020

Figure 06: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Share Analysis (%), By Company, 2020

PUBLISHED ON:Feb, 2022
BASE YEAR:2020
HISTORICAL DATA: 2017-2019
NO OF PAGES: 122

Healthcare Clients

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry

Get in Touch with Us

+1 424 253 0390 (US)
+44 2071 939123 (UK)
+91 744 740 1245 (APAC)
[email protected]

Features		Type of License
Features		Single User	Multi User	Enterprise User
Pricing		US$ 3850	US$ 4850	US$ 6850
Number of Users Who can Access the Report		1 user only	2 to 6 users	Unlimited access within the organization
Free Customization		20 hours	40 hours	60 hours
Duration of Free Analyst Support		3 months post purchase	6 months post purchase	12 months post purchase
Direct access to the Analyst Team (through calls/email)
Deliverable Format	PDF
	Excel
	Power Point
Discount on Your Next Purchase (applicable to 1 report only for the same license type)		No Discount	15%	25%
Permission to Print the Report